Join
Live feed
·
SECFilingvia Quantisnow
Protalix BioTherapeutics Inc. (DE) logo

Protalix BioTherapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
PLX· Protalix BioTherapeutics Inc. (DE)
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLX (Protalix BioTherapeutics Inc. (DE)) and more on Quantisnow.